PRE-DETERMINE Cohort Study
Study Details
Study Description
Brief Summary
This is a prospective, multi-center cohort study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). The primary objective of this study is to determine whether biologic markers and ECGs can be utilized to advance SCD risk prediction in patients with CHD and LVEF>30-35%. The overarching goal of the study is to identify a series of markers that alone or in combination specifically predict risk of arrhythmic death as compared to other causes of mortality among this at risk population of coronary heart disease (CHD) patients with preserved left ventricular ejection fraction (LVEF> 30-35%). If biologic or ECG markers are identified that can specifically predict risk of ventricular arrhythmias, then these markers may serve as relatively inexpensive methods to identify those at risk. The public health impact of identifying markers could be quite substantial, leading to more efficient utilization of ICDs and advances in our understanding of mechanisms underlying SCD.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The PRE-DETERMINE Study is a prospective, multi-center study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). Patients were enrolled at 135 sites where information on baseline demographics, clinical characteristics, pertinent past medical history, lifestyle habits, cardiac test results, and medications were collected via electronic data capture. Electrocardiograms along with a blood sample was also collected at baseline, sent to central laboratories, and stored for future analyses. Contrast-enhanced magnetic resonance imaging (CE-MRI) scans were collected on a subset of patients and analyzed. Enrollment closed in November 2013 and patients are now being followed centrally by the Clinical Coordinating Center via mail/phone to document interim non-fatal arrhythmic events and cause-specific mortality. Questionnaires that inquire about intervening ICD implantations, ICD therapies, cardiac arrest, and other pertinent cardiovascular endpoints are mailed to participants every six months, and follow-up telephone calls are made to non-responders. Study endpoints are being confirmed through review of medical records, interviews with next-of-kin, and autopsy reports, if available.
Study Design
Outcome Measures
Primary Outcome Measures
- Sudden and/or arrhythmic cardiac death or resuscitated ventricular fibrillation. [Median follow-up estimated to be 8 years]
A definite sudden cardiac death (SCD) is defined as a death or fatal cardiac arrest occurring within 1 hour of symptom onset or the presence of autopsy consistent with SCD (e.g. acute coronary thrombosis). Probable SCD is defined as an unwitnessed death or death during sleep where the participant was observed to be symptom-free within the preceding 24 hours. Arrhythmic death is defined as the abrupt spontaneous collapse of circulation without antecedent circulatory or neurologic impairment. Deaths classified as non-arrhythmic are not included in the primary endpoint regardless of timing. Resuscitated ventricular fibrillation is defined as out-of-hospital cardiac arrests with documented VF and/or use of external electrical defibrillation for resuscitation.
Secondary Outcome Measures
- ICD Shock [Median follow-up estimated to be 8 years]
ICD therapies for ventricular arrhythmias over 200 BPMs will be added to the endpoint.
- ICD Implantation [Median follow-up estimated to be 8 years]
- Total Cardiac Mortality [Median follow-up estimated to be 8 years]
- Total Mortality [Median follow-up estimated to be 8 years]
- Non-Sudden or Arrhythmic Causes of Mortality [Median follow-up estimated to be 8 years]
Competing causes of mortality in competing risk analyses.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Evidence of Coronary Artery Disease (CAD) a or documented prior Myocardial Infarction.
-
LVEF >35% by any current standard evaluation technique (e.g.,) echocardiogram, MUGA, angiography). 2.1. Patients who have an LVEF between 30-35% and NYHA Class I heart failure who do not have history of ventricular tachyarrhythmias,or inducible ventricular tachycardia during electrophysiological (EP) testing can be enrolled.
-
If documented prior MI is not present, evidence of mild-moderate systolic Left Ventricular Dysfunction with an EF >35- ≤50% as measured by any current standard screening technique (e.g.,echocardiogram, MUGA, angiography) must be present.
-
Patients aged 18 years or above
-
CAD will be defined as evidence of one of the following two (2) criteria:
-
Significant stenosis of a major epicardial vessel (>50% proximal or 70% distal) by coronary angiography
-
Prior revascularization (percutaneous coronary intervention or coronary artery bypass surgery)
- MI can be documented in the following ways:
-
From the MI hospitalization: Detection of a rise and fall of cardiac biomarkers > 99th percentile of lab (e.g., CPK elevation or Troponin at least > two times the upper limit of normal) together with myocardial ischemia with at least one of the following:
-
Symptoms of Ischemia
-
ECG changes indicative of new ischemia (new ST-T changes or new LBBB)
-
Development of pathological Q waves
-
Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality
-
If no report from the MI hospitalization is available, prior MI can be met by either of the following:
-
Development of pathological Q waves
-
Imaging evidence of a region of loss of viable myocardium that is thinned and fails to contract, in the absence of a non-ischaemic cause
Exclusion Criteria:
-
History of cardiac arrest or spontaneous or inducible sustained VT (15 beats or more at a rate of 120 BPM or greater - the occurrence of cardiac arrest or spontaneous VT in the setting of an acute MI is not considered an exclusion).
-
Unexplained syncope
-
Current or planned implantable cardiac defibrillator (ICD)
-
Any condition other than cardiac disease that, in the investigator's judgment, would seriously limit life expectancy (poor survival)
-
Metastatic cancer
-
Marked valvular heart disease requiring surgical intervention
-
Current or planned cardiac, renal or liver transplant
-
Current alcohol or drug abuse
-
Unwilling or unable to provide informed consent
-
LVEF <35% with Class II-IV CHF or LVEF <30%
-
Participation in a clinical trial where the active treatment arm is testing an agent and/or intervention with known antiarrhythmic properties
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Alaska Heart Institute | Anchorage | Alaska | United States | 99508 |
2 | Phoenix Heart, PLLC | Glendale | Arizona | United States | 85306 |
3 | Cardiovascular Consultants | Phoenix | Arizona | United States | 85032 |
4 | Beaver Medical Group/Clinical Care Research | Banning | California | United States | 92220 |
5 | Memorial Health System | Colorado Springs | Colorado | United States | 80909 |
6 | Colorado Heart and Vascular | Denver | Colorado | United States | 80204 |
7 | Bay Area Cardiology Associates, P.A. | Brandon | Florida | United States | 33511 |
8 | University of Florida - Gainsville | Gainesville | Florida | United States | 32610 |
9 | Mount Sinai Medical Center | Miami Beach | Florida | United States | 33140 |
10 | Reliable Clinical Research | Miami | Florida | United States | 33135 |
11 | Florida Hospital | Orlando | Florida | United States | 32804 |
12 | Orlando Regional Medical Center | Orlando | Florida | United States | 32806 |
13 | Palm Beach Gardens Research Center | Palm Beach Gardens | Florida | United States | 33410 |
14 | Velella Research | Sarasota | Florida | United States | 34233 |
15 | Tallahassee Research Institute, Inc. | Tallahassee | Florida | United States | 32308 |
16 | Cardiology Associates of Palm Beach - West Palm Beach | West Palm Beach | Florida | United States | 33401 |
17 | Georgia Heart Specialist | Covington | Georgia | United States | 30014 |
18 | Northeast Georgia Heart Center, P.C. | Gainesville | Georgia | United States | 30501 |
19 | University of Chicago | Chicago | Illinois | United States | 60637 |
20 | Advocate Medical Group | Chicago | Illinois | United States | 60643 |
21 | Advocate Medical Group - Heart and Vascular of IL | Chicago | Illinois | United States | 60657 |
22 | Consultants in Cardiovascular Medicine | Melrose Park | Illinois | United States | 60160 |
23 | Community Heart and Vascular | Anderson | Indiana | United States | 46011 |
24 | Iowa Heart Center | West Des Moines | Iowa | United States | 50266 |
25 | The University of Kansas | Kansas City | Kansas | United States | 66160 |
26 | Baptist Health Lexington | Lexington | Kentucky | United States | 40503 |
27 | Leonard J. Chabert Medical Center | Houma | Louisiana | United States | 70363 |
28 | Maine Research Associates | Auburn | Maine | United States | 04210 |
29 | Maine Research Associates - Lewiston | Lewiston | Maine | United States | 04240 |
30 | University of Maryland Medical Center | Baltimore | Maryland | United States | 21201 |
31 | Primary Care Cardiology Research | Ayer | Massachusetts | United States | 01432 |
32 | Brigham and Women's Hospital | Boston | Massachusetts | United States | 02115 |
33 | NECCR Internal Medicine and Cardiology Associates, LLC | Fall River | Massachusetts | United States | 02720 |
34 | Hawthorn Medical Associates | North Dartmouth | Massachusetts | United States | 02747 |
35 | Baystate Cardiology | Springfield | Massachusetts | United States | 01199 |
36 | University of Michigan Medical Center | Ann Arbor | Michigan | United States | 48109 |
37 | Oakwood Hospital & Medical Center | Dearborn | Michigan | United States | 48124 |
38 | McLaren Medical Center - Macomb | Mount Clemens | Michigan | United States | 48043 |
39 | Michigan Heart | Ypsilanti | Michigan | United States | 48197 |
40 | Minneapolis VA Medical Center | Minneapolis | Minnesota | United States | 55417 |
41 | University of Missouri Health Care | Columbia | Missouri | United States | 65201 |
42 | Glacier View Cardiology | Kalispell | Montana | United States | 59901 |
43 | The Cardiac Center of Creighton University | Omaha | Nebraska | United States | 68131 |
44 | Advanced Heartcare, LLC | Bridgewater | New Jersey | United States | 08807 |
45 | St. Joseph Regional Medical Center | Paterson | New Jersey | United States | 07503 |
46 | New Mexico VA Healthcare Systems | Albuquerque | New Mexico | United States | 87108 |
47 | Albany Associates Cardiology | Albany | New York | United States | 12205 |
48 | Maimonides Medical Center | Brooklyn | New York | United States | 11219 |
49 | Buffalo General Hospital/Kaleida Health | Buffalo | New York | United States | 14203 |
50 | Jamaica Hospital Medical Center | Jamaica | New York | United States | 11418 |
51 | Mid-Valley Cardiology | Kingston | New York | United States | 12401 |
52 | Winthrop-University Hospital | Mineola | New York | United States | 11501 |
53 | Gotham Cardiovascular | New York | New York | United States | 10001 |
54 | Columbia University Health Center | New York | New York | United States | 10032 |
55 | Stony Brook University Medical Center | Stony Brook | New York | United States | 11794 |
56 | St. Elizabeth Medical Center - Hotvedt | Utica | New York | United States | 13501 |
57 | Asheville Cardiology Associates | Asheville | North Carolina | United States | 28801 |
58 | Eastern Carolina Cardiovascular | Elizabeth City | North Carolina | United States | 27909 |
59 | Northstate Clinical Research | Lenoir | North Carolina | United States | 28645 |
60 | Pinehurst Medical Clinic, Inc. | Pinehurst | North Carolina | United States | 28374 |
61 | Sanford Cardiology | Sanford | North Carolina | United States | 27330 |
62 | Wake Forest | Winston-Salem | North Carolina | United States | 27157 |
63 | Northeast Ohio Cardiovascular Specialists | Akron | Ohio | United States | 44304 |
64 | University of Cincinnati | Cincinnati | Ohio | United States | 45267 |
65 | MetroHealth Medical Center | Cleveland | Ohio | United States | 44109 |
66 | North Ohio Research, Ltd. | Elyria | Ohio | United States | 44035 |
67 | Mercy Medical Associates | Fairfield | Ohio | United States | 45014 |
68 | Northwest Ohio Cardiology Consultants/The Toledo Hospital | Toledo | Ohio | United States | 43615 |
69 | Oklahoma City VA Medical Center Veterans Research and Education Foundation | Oklahoma City | Oklahoma | United States | 73104 |
70 | Oklahoma Foundation for Cardiovascular Research | Oklahoma City | Oklahoma | United States | 73120 |
71 | Abington Memorial Hospital | Abington | Pennsylvania | United States | 19001 |
72 | St. Luke's Bethlehem | Bethlehem | Pennsylvania | United States | 18018 |
73 | Doylestown Cardiology Associates | Doylestown | Pennsylvania | United States | 18901 |
74 | Allegheny General Hospital | Pittsburgh | Pennsylvania | United States | 15212 |
75 | University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | United States | 15213 |
76 | AnMed Health | Anderson | South Carolina | United States | 29621 |
77 | VA Medical Center - Charleston | Charleston | South Carolina | United States | 29425 |
78 | Carolina Cardiology Associates | Rock Hill | South Carolina | United States | 29732 |
79 | Black Hills Cardiovascular Research | Rapid City | South Dakota | United States | 57701 |
80 | Cardiovasular Research of Knoxville | Knoxville | Tennessee | United States | 37917 |
81 | Memphis VA Medical Center | Memphis | Tennessee | United States | 38104 |
82 | St. Luke's Episcopal Hospital | Houston | Texas | United States | 77030 |
83 | Non-Invasive Cardiovascular PA | Houston | Texas | United States | 77074 |
84 | Providence Health Center | Waco | Texas | United States | 76712 |
85 | Intermountain Medical Center | Murray | Utah | United States | 84157 |
86 | Cardiovascular Associates Virginia Beach | Virginia Beach | Virginia | United States | 23454 |
87 | University of Alberta | Edmonton | Alberta | Canada | T6G 2B7 |
88 | Vancouver General Hospital | Vancouver | British Columbia | Canada | V5Z 1M9 |
89 | Mississauga Clinical Research Centre | Mississauga | Ontario | Canada | L5B 2P7 |
90 | Transcatheter Medical, Inc. Centro Cardiovascular de Caguas y del Caribe | Rio Piedras | Puerto Rico | 00924 |
Sponsors and Collaborators
- Brigham and Women's Hospital
- National Heart, Lung, and Blood Institute (NHLBI)
- Abbott Medical Devices
- Northwestern University
- Roche Diagnostics
- Quintiles, Inc.
Investigators
- Principal Investigator: Christine M Albert, M.D., M.P.H., Brigham and Women's Hospital
Study Documents (Full-Text)
None provided.More Information
Additional Information:
- Cardiac Arrest
- Coronary Artery Disease
- Pacemakers and Implantable Defibrillators
- U.S. FDA Resources
- Heart Disease
Publications
None provided.- 2007P000840
- R01HL091069